Clearmind Medicine Inc. Gains Losses On Change In Fair Value Of Derivatives
Clearmind Medicine Inc. (CMND) reported Gains Losses On Change In Fair Value Of Derivatives of $365.93 thousand for the 3-month period ending 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Income Statement › Other Income
ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives · last filed 2026-03-12
- Clearmind Medicine Inc. gains losses on change in fair value of derivatives for the quarter ending 2026-01-31 was $365.93K, a 28.91% decline year-over-year.
- Clearmind Medicine Inc. gains losses on change in fair value of derivatives for the quarter ending 2025-10-31 was -$190.50K, a 124.09% decline year-over-year.
- Clearmind Medicine Inc. gains losses on change in fair value of derivatives for the quarter ending 2025-07-31 was $139.56K.
- Clearmind Medicine Inc. gains losses on change in fair value of derivatives for the quarter ending 2025-04-30 was $664.77K, a 64.14% increase year-over-year.
| Period end | Gains Losses On Change In Fair Value Of Derivatives 3 month | Gains Losses On Change In Fair Value Of Derivatives 6 month | Gains Losses On Change In Fair Value Of Derivatives 9 month | Gains Losses On Change In Fair Value Of Derivatives 12 month | Gains Losses On Change In Fair Value Of Derivatives 12 month as first filed | Gains Losses On Change In Fair Value Of Derivatives 15 month |
|---|---|---|---|---|---|---|
| 2026-01-31 | $365.93K 6-K · filed 2026-03-12 | $175.43K derived: sum of 2 quarters · filed 2026-03-12 | $314.99K derived: sum of 3 quarters · filed 2026-03-12 | $979.76K derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2025-10-31 | -$190.50K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$50.93K derived: sum of 2 quarters · filed 2026-01-20 | $613.84K derived: sum of 3 quarters · filed 2026-01-20 | $1.13M 20-F · filed 2026-01-20 | ||
| 2025-07-31 | $139.56K 6-K · filed 2025-09-11 | $804.33K derived: sum of 2 quarters · filed 2025-09-11 | $1.32M 6-K · filed 2025-09-11 | $2.11M derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2025-04-30 | $664.77K 6-K · filed 2025-06-12 | $1.18M 6-K · filed 2025-06-12 | $1.97M derived: sum of 3 quarters · filed 2026-03-12 | $1.33M derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2025-01-31 | $514.75K 6-K · filed 2026-03-12 | $1.31M derived: sum of 2 quarters · filed 2026-03-12 | $662.41K derived: sum of 3 quarters · filed 2026-03-12 | $1.07M derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2024-10-31 | $790.88K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $147.66K derived: sum of 2 quarters · filed 2026-01-20 | $552.66K derived: sum of 3 quarters · filed 2026-01-20 | $707.80K 20-F · filed 2026-01-20 | ||
| 2024-07-31 | -$643.23K 6-K · filed 2025-09-11 | -$238.22K derived: sum of 2 quarters · filed 2025-09-11 | -$83.08K 6-K · filed 2025-09-11 | -$2.39M derived: sum of 4 quarters · filed 2026-01-20 | ||
| 2024-04-30 | $405.00K 6-K · filed 2025-06-12 | $560.14K 6-K · filed 2025-06-12 | -$1.75M derived: sum of 3 quarters · filed 2026-01-20 | -$1.27M derived: sum of 4 quarters · filed 2026-01-20 | $405.00K 6-K · filed 2024-06-13 | |
| 2024-01-31 | $155.14K 6-K · filed 2025-03-13 | -$2.16M derived: sum of 2 quarters · filed 2026-01-20 | -$1.67M derived: sum of 3 quarters · filed 2026-01-20 | -$2.03M derived: sum of 4 quarters · filed 2026-01-20 | ||
| 2023-10-31 | -$2.31M derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$1.83M derived: sum of 2 quarters · filed 2026-01-20 | -$2.19M derived: sum of 3 quarters · filed 2026-01-20 | -$2.19M 20-F · filed 2026-01-20 | $2.19M 6-K · filed 2024-03-19 | |
| 2023-07-31 | $482.33K 6-K · filed 2024-09-16 | $121.77K derived: sum of 2 quarters · filed 2024-09-16 | $121.77K 6-K · filed 2024-09-16 | |||
| 2023-04-30 | -$360.56K 6-K · filed 2024-06-13 | -$360.56K 6-K · filed 2024-06-13 | ||||
| 2022-10-31 | -$290.57K 20-F · filed 2025-01-22 |